SCHEMBL15030902

SCHEMBL15030902

Cc1ccc(NC(=O)NCc2ccc(N)nc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.68
NAMPT P43490 8/20 0.67
HDAC1 Q13547 1/20 0.63
RAB9A P51151 3/20 0.60
SMN1; SMN2 Q16637 4/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
TP53 P04637 1/20 0.59
HPGD P15428 1/20 0.59
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA9 Q16790 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.53
POLB P06746 2/20 0.51
MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15030897 0.84 NPC1 (0.65) NPC1NAMPTRAB9ASMN1; SMN2MEN1
SCHEMBL165038 0.80 NAMPT (1.00) NAMPTHDAC1
SCHEMBL29635786 0.80 NAMPT (1.00) NAMPTHDAC1
SCHEMBL164472 0.79 NAMPT (1.00) NAMPTHDAC1
SCHEMBL18291355 0.79 NAMPT (0.53) NAMPTHDAC1SMN1; SMN2MEN1KMT2A
SCHEMBL874752 0.78 NAMPT (0.52) NAMPTHDAC1SMN1; SMN2MEN1KMT2A
SCHEMBL18286275 0.78 GABRP (0.61) NAMPTHDAC1SMN1; SMN2
SCHEMBL14617679 0.77 PPIB (0.58) NPC1NAMPTHDAC1RAB9ASMN1; SMN2
SCHEMBL10290541 0.77 NAMPT (0.84) NAMPTSMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL3154000 0.76 MASP2 (0.50) NAMPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012031196-A9 4- { [ ( PYRIDIN- 3 - YL -METHYL) AMINOCARBONYL] AMINO} BENZENE - SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER FORMA TM, LLC (US) 2013-06-13 WO disclosed